Pregnancy Outcomes Following Macitentan or Bosentan Exposure Before or During Pregnancy: Review of Cases Reported to the Manufacturer's Global Safety Database

Documenti analoghi

• How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
  di: Ivan M. Robbins, et al.
  Pubblicazione: (2025)
• Obituary: John H. Newman, MD
  di: Ivan Robbins, et al.
  Pubblicazione: (2024)
• Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension
  di: Teresa Segura de la Cal, et al.
  Pubblicazione: (2026)
• Alterations in ECG and Right Heart Catheterization Data in PAH Patients Who Died From Sudden Death Compared With Right Heart Failure
  di: Alexandra B. Flemington, et al.
  Pubblicazione: (2025)
• SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation
  di: Robert P. Frantz, et al.
  Pubblicazione: (2024)